Ulcerative Colitis

>

On the HCPLive Ulcerative Colitis condition center page, resources on the topics of medical news and expert insight into colitis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on UC research, treatment, and drug development.

Latest News

Infliximab Improves Ulcerative Colitis, Crohn's Disease Regardless of Immunosuppressants
Infliximab Improves Ulcerative Colitis, Crohn's Disease Regardless of Immunosuppressants

October 27th 2024

Post hoc analyses from the LIBERTY trials support infliximab as either a monotherapy or combination therapy for ulcerative colitis or Crohn's disease.

FDA black and white logo | Credit: US Food and Drug Administration
FDA Approves Guselkumab (Tremfya) for Ulcerative Colitis

September 11th 2024

HCPLive Gastroenterology Month in Review: July 2024 | Credit: HCPLive
Gastroenterology Month in Review: July 2024

August 3rd 2024

Gilaad Kaplan, MD, MPH | Credit: University of Calgary
Risankizumab Induction, Maintenance Therapy Improves Clinical Remission Rates in UC

July 22nd 2024

HCPLive Gastroenterology Month in Review: June 2024
Gastroenterology Month in Review: June 2024

July 4th 2024

© 2024 MJH Life Sciences

All rights reserved.